Clinical Trial Update: Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating selective early medical treatment of patent ductus arteriosus in extremely preterm infants; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Snippet

Sponsor: IWK Health Centre | Conditions: Patent Ductus Arteriosus After Premature Birth | Phase 3 | Status: RECRUITING